Login / Signup

Activity Promotion of Core and Shell in Multifunctional Core-Shell Co2 P@NC Electrocatalyst by Secondary Metal Doping for Water Electrolysis and Zn-Air Batteries.

Xian-Wei LvWei-Shan XuWen-Wen TianHao-Yu WangZhong-Yong Yuan
Published in: Small (Weinheim an der Bergstrasse, Germany) (2021)
Developing cost-efficient multifunctional electrocatalysts is highly critical for the integrated electrochemical energy-conversion systems such as water electrolysis based on hydrogen/oxygen evolution reactions (HER/OER) and metal-air batteries based on OER/oxygen reduction reactions (ORR). The core-shell structured materials with transition metal phosphide as the core and nitrogen-doped carbon (NC) as the shell have been known as promising HER electrocatalysts. However, their oxygen-related electrocatalytic activities still remain unsatisfactory, which severely limits their further applications. Herein an effective strategy to improve the core and shell performances of core-shell Co2 P@NC electrocatalysts through secondary metal (e.g., Fe, Ni, Mo, Al, Mn) doping (termed M-Co2 P@M-N-C) is reported. The as-synthesized M-Co2 P@M-N-C electrocatalysts show multifunctional HER/OER/ORR activities and good integrated capabilities for overall water splitting and Zn-air batteries. Among the M-Co2 P@M-N-C catalysts, Fe-Co2 P@Fe-N-C electrocatalyst exhibits the best catalytic activities, which is closely related to the configuration of highly active species (Fe-doping Co2 P core and Fe-N-C shell) and their subtle synergy, and a stable carbon shell for outstanding durability. Combination of electrochemical-based in situ Fourier transform infrared spectroscopy with extensive experimental investigation provides deep insights into the origin of the activity and the underlying electrocatalytic mechanisms at the molecular level.
Keyphrases
  • metal organic framework
  • transition metal
  • gold nanoparticles
  • heavy metals
  • solid state
  • drug delivery
  • mass spectrometry
  • molecularly imprinted
  • visible light
  • cancer therapy